Fostering the cooperation between Europe and China in Personalised Medicine
The Sino-EU PerMed project, funded by Horizon 2020, the EU's Framework Programme for Research and Innovation, has been launched in January 2020. A unique bi-regional consortium of 6 partners from governmental, funding and research organisations supported by leading stakeholders as associated partners will promote personalised medicine cooperation between Europe and China.
The aim of personalised medicine is to improve diagnosis and treatment of diseases and strengthen prevention strategies by taking into account the patient's geno- and phenotypes as well as biomedical, lifestyle and environmental factors. Sino-EU PerMed will engage China in the International Consortium on Personalised Medicine (ICPerMed) to advance the implementation of the Action Plan of ICPerMed.
Sino-EU PerMed is built on 4 pillars:
- The project's backbone: Coordination and Management
- The project's senses: Mapping of landscape and stakeholders
- The project's heart: Science & Policy Dialogue between Europe and China / ICPerMed: establish a common understanding and work on common activities and goals
- The project's brain: Paving the Science &Technology (S&T) way to Europe – China collaboration in PerMed: drafting concepts of the future